Labguru
19 February 2015
BioData has announced that the Innovative Medicines unit of the pharmaceutical giant AstraZeneca, has adopted the Labguru platform for the global management of biological reagents used in pre-clinical research
BioData has announced that the Innovative Medicines unit of the pharmaceutical giant AstraZeneca, has adopted the Labguru platform for the global management of biological reagents used in pre-clinical research